BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18547811)

  • 1. New trypanocidal hybrid compounds from the association of hydrazone moieties and benzofuroxan heterocycle.
    Porcal W; Hernández P; Boiani L; Boiani M; Ferreira A; Chidichimo A; Cazzulo JJ; Olea-Azar C; González M; Cerecetto H
    Bioorg Med Chem; 2008 Jul; 16(14):6995-7004. PubMed ID: 18547811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives.
    Porcal W; Hernández P; Boiani M; Aguirre G; Boiani L; Chidichimo A; Cazzulo JJ; Campillo NE; Paez JA; Castro A; Krauth-Siegel RL; Davies C; Basombrío MA; González M; Cerecetto H
    J Med Chem; 2007 Nov; 50(24):6004-15. PubMed ID: 17960923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-trypanosomatid benzofuroxans and deoxygenated analogues: synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies.
    Castro D; Boiani L; Benitez D; Hernández P; Merlino A; Gil C; Olea-Azar C; González M; Cerecetto H; Porcal W
    Eur J Med Chem; 2009 Dec; 44(12):5055-65. PubMed ID: 19837489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents.
    Augustyns K; Amssoms K; Yamani A; Rajan PK; Haemers A
    Curr Pharm Des; 2001 Aug; 7(12):1117-41. PubMed ID: 11472257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
    Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
    Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?
    Boiani M; Piacenza L; Hernández P; Boiani L; Cerecetto H; González M; Denicola A
    Biochem Pharmacol; 2010 Jun; 79(12):1736-45. PubMed ID: 20178775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
    Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
    Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 2-methyl-1H-benzimidazole-5-carbohydrazides derivatives as modifiers of redox homeostasis of Trypanosoma cruzi.
    Melchor-Doncel de la Torre S; Vázquez C; González-Chávez Z; Yépez-Mulia L; Nieto-Meneses R; Jasso-Chávez R; Saavedra E; Hernández-Luis F
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3403-3407. PubMed ID: 28648464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents.
    Caputto ME; Fabian LE; Benítez D; Merlino A; Ríos N; Cerecetto H; Moltrasio GY; Moglioni AG; González M; Finkielsztein LM
    Bioorg Med Chem; 2011 Nov; 19(22):6818-26. PubMed ID: 22000947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
    González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
    Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
    Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
    Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi.
    de Moraes Gomes PAT; de Oliveira Barbosa M; Farias Santiago E; de Oliveira Cardoso MV; Capistrano Costa NT; Hernandes MZ; Moreira DRM; da Silva AC; Dos Santos TAR; Pereira VRA; Brayner Dos Santosd FA; do Nascimento Pereira GA; Ferreira RS; Leite ACL
    Eur J Med Chem; 2016 Oct; 121():387-398. PubMed ID: 27295485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
    Porcal W; Hernández P; Aguirre G; Boiani L; Boiani M; Merlino A; Ferreira A; Maio RD; Castro A; González M; Cerecetto H
    Bioorg Med Chem; 2007 Apr; 15(7):2768-81. PubMed ID: 17287123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naftifine-analogues as anti-Trypanosoma cruzi agents.
    Gerpe A; Boiani L; Hernández P; Sortino M; Zacchino S; González M; Cerecetto H
    Eur J Med Chem; 2010 Jun; 45(6):2154-64. PubMed ID: 20163894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi.
    Costa LB; Cardoso MV; de Oliveira Filho GB; de Moraes Gomes PA; Espíndola JW; de Jesus Silva TG; Torres PH; Silva Junior FP; Martin J; de Figueiredo RC; Leite AC
    Bioorg Med Chem; 2016 Apr; 24(8):1608-18. PubMed ID: 26964673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
    Maya JD; Rodríguez A; Pino L; Pabón A; Ferreira J; Pavani M; Repetto Y; Morello A
    Biol Res; 2004; 37(1):61-9. PubMed ID: 15174306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-based design, synthesis, and experimental evaluation of novel benzofuroxan derivatives as anti-Trypanosoma cruzi agents.
    Jorge SD; Palace-Berl F; Mesquita Pasqualoto KF; Ishii M; Ferreira AK; Berra CM; Bosch RV; Maria DA; Tavares LC
    Eur J Med Chem; 2013 Jun; 64():200-14. PubMed ID: 23644203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.